🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a multicenter study to evaluate the efficacy and safety of MK0476 v...
Status
Completed
Location
Multiple Locations
Start Date
2006-05
Trial ID
NCT00284856
Treatments Being Tested
Eurofarma Laboratórios S.A. markets a FDC containing formoterol 12 mcg/flut...
Status
Withdrawn
Location
Eurofarma Laboratorios S.A
Start Date
2026-06
Trial ID
NCT05735431
Treatments Being Tested
The purpose of this study is to determine whether patients with asthma who ...
Status
Completed
Location
Maternal and Child Health Sciences, Ninewells Hospital and Medical School
Start Date
2007-08
Trial ID
NCT00655616
Treatments Being Tested
This study is to evaluate the equivalence of generic Azelastine Hydrochlori...
Status
Unknown
Location
Multiple Locations
Start Date
2013-12
Trial ID
NCT02279563
The study is aimed to assess the dose proportional total systemic exposure ...
Status
Completed
Location
The Medicine Evaluation Unit
Start Date
2012-11
Trial ID
NCT01738087
Treatments Being Tested
A randomised, double-blind, placebo-controlled, parallel group multicentre ...
Status
Completed
Location
GSK Investigational Site
Start Date
2012-01
Trial ID
NCT01498679
Treatments Being Tested
The purpose of this study is to evaluate the long-term safety of fluticason...
Status
Completed
Location
GSK Investigational Site
Start Date
2009-10-19
Trial ID
NCT01018186
Treatments Being Tested
This study will evaluate the effects of inhaled fluticasone on cell counts ...
Status
Completed
Location
Multiple Locations
Start Date
2009-03
Trial ID
NCT00869596
This is a patient level randomized trial for teenagers and adults with asth...
Status
Completed
Location
DARTNet Insitute
Start Date
2024-02-01
Trial ID
NCT06272370
Treatments Being Tested
The purpose of this study is to demonstrate the pharmacodynamic bioequivale...
Status
Completed
Location
Combined Research Orlando
Start Date
2018-10-17
Trial ID
NCT03394989